ProtaGene is a world-leading CRO partner for the biopharmaceutical and gene and cell therapy industries. ProtaGene's deep history of analytical leadership in protein-based therapies stems from the merger of Protagen Protein Services in Europe and BioAnalytix in the US. In 2021, GeneWerk's unique capabilities in vector safety, integration site analysis, and bioinformatics were added to their portfolio, establishing ProtaGene. The organization operates four sites in Europe and North America and works in advanced therapeutic platforms with leading companies worldwide.
Brands: Vector Analytics • Gene Expression & Integration Site Analysis • Genetic Analytics • Bioinformatics • Product Characterization & Attribute Analysis • Product & Process Development • Manufacturing & QC